Lyme disease, one of several infections caused by the bacterium Borrelia burgdorferi, is a tick-borne illness that can lead to persistent symptoms even after standard antibiotic treatment. For patients experiencing neurological or chronic effects, Hyperbaric Oxygen Therapy (HBOT) has emerged as a potential adjunctive therapy.
What is HBOT?
HBOT involves breathing enriched oxygen in a pressurized chamber, allowing oxygen to dissolve more effectively into the plasma and other fluids and reach tissues with limited blood flow. Increased oxygenation and pressure enhance the body’s natural healing processes.
Potential Benefits of HBOT for Lyme Disease
- Enhanced Oxygen Delivery: HBOT increases oxygen concentration in the blood, aiding in the recovery of tissues affected by Lyme disease.
- Kills off the Spirochete: the bacterium that causes Lyme is a micro-anaerobe and dies when exposed to high levels of oxygen.
- Reduction of Inflammation: Increased oxygen levels are a natural anti-inflammatory, and Lyme can create inflammation anywhere in the body, including in the brain.
- Support for Neurological Symptoms: HBOT spurs neuroplasticity, helping the brain heal. Patients report improvements in cognitive function and reduction in neurological symptoms following HBOT sessions.
- Normalizes Immune Function: HBOT addresses immune dysfunction, often disrupted by Lyme and co-infections.
- Increase the effectiveness of other medications: HBOT enhances the effectiveness of antibiotics.
Study Highlights
A 2014 case report published in the Journal of the Chinese Medical Association detailed the treatment of a 31-year-old male patient with chronic Lyme disease who experienced significant symptom relief after undergoing 30 HBOT sessions. The patient reported resolution of neurological symptoms such as irritability, mood swings, poor concentration, and sleep disturbances, as well as musculoskeletal issues like joint pain. The authors concluded that HBOT may serve as an effective adjunctive treatment for chronic Lyme disease, particularly in cases unresponsive to conventional therapies.
A 2023 ResearchGate systematic review and meta-analysis of fibromyalgia, a common diagnosis for people suffering from chronic Lyme and Coinfections, reports that HBOT improved pain, tender points, fatigue, multidimensional function, patient global and sleep disturbance in FM, with reversible side effects. Low pressure (less than 2.0 atmospheric absolute) may be beneficial to reduce adverse events in FM.
The post Lyme Disease & HBOT: A Glimpse of Hope first appeared on Hyperbaric Vermont.
The post Lyme Disease & HBOT: A Glimpse of Hope appeared first on Hyperbaric Vermont.